Forendo Pharma (private company)

See something wrong or missing? Let us know
Offices:
Turku
Business model:
B2B
Investors:
we tracked 8 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 4 transactions

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Forendo Pharma is a drug development company based in Turku, Finland, with core competence in organ specific hormone mechanisms, giving new opportunities to unmet needs in women ́s and men ́s health.

Companies with similar profile to Forendo Pharma:

CompanyCriteria
Denmark NMD Pharma
66%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark AFYX Therapeutics
66%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Synoste Oy
65%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Innovestor Ventures
  • At least one other investor: Finnvera
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Galecto Biotech
65%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds, Sunstone Life Science Ventures
  • At least one other investor: Merck Ventures
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden AMRA
55%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden OxThera
55%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Acarix
55%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden ITBMed
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Asarina Pharma
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Glucostratus (Mendor)
53%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: Finnvera
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Aprea Therapeutics
53%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: Karolinska Development
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Modus Therapeutics
53%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: Karolinska Development
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark MinervaX
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds, Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
Finland Tenboron
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Innovestor Ventures
  • At least one other investor: Finnvera
Norway Vaccibody
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Finland Nanoform Finland
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Sweden Gesynta Pharma
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: Karolinska Development
Finland BitBar
44%
  • Similar business models: B2B
  • At least one vc investor: Innovestor Ventures
  • At least one other investor: Finnvera
  • Minim one investor from outside Scandinavia: Yes
Denmark Orphazyme
44%
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Athera
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: Karolinska Development

News about Forendo Pharma

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)